If the results are positive - as we believe they will be - we are going to see a tiny $7 company go absolutely vertical...
Already, biotech insiders are swarming...
In fact, they've grabbed up nearly 9 out of 10 available shares.
It won't take much buying pressure to push this tiny company to $14... $28... even $56 a share...
And now, a $900 billion Swiss investment firm - banker to over half the world's billionaires - has just ramped up its stake by over 4,000%!
FRENZY: Phase 3 results could spark 72,500% revenue explosion starting Sept. 30 - click here now.
The writing is on the wall, and the time for action is now...
When you add it all up, a conservative projection sees this company experiencing a 72,500% revenue explosion.
Again, insiders and institutions have snapped up nearly 90% of available shares, and you need to move fast to avoid missing out.
Phase 3 results are expected any day now and are due by Sept. 30.
And because almost 90% of the available shares are already spoken for...
... heavy institutional buying could push this tiny $7 stock out of reach before the phase 3 results are even released.
In other words, you need to move fast to avoid missing out on your shot.
Follow Money Morning on Facebook, Twitter, and LinkedIn.
[mmpazkzone name="end-story-hostage" network="9794" site="307044" id="138536" type="4"]